Insurance experts feel that pricing insurance policies that cover COVID-19 treatment is posing a major challenge for the insurers, especially the private players, as the reinsurers are hesitant to underwrite the risk.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
Brought to you by